Functionalization of a carbon nanofiber with a tetrasulfonatophenyl ruthenium(II)porphine complex for real-time amperometric sensing of chlorpromazine

Highly sensitive and novel dual-emission fluorescence nanosensor utilizing hybrid carbon dots-quantum dots for ratiometric determination of chlorpromazine

Herein, a ratiometric fluorimetric nanosensor is introduced for the sensitive and selective analysis of chlorpromazine (CPZ) via employing blue-emitting B-doped carbon dots (B-CDs) as the reference fluorophore and green-emitting CdTe capped thioglycolic acid (TGA) quantum dots (TGA-CdTe-QDs) as the specific recognition probe. The sensor exhibits dual emission centered at 440 and 560 nm, under a single excitation wavelength of 340 nm. Upon the addition of ultra-trace amount of CPZ, the fluorescence signal of TGA-CdTe-QDs declines due to electron transfer process from excited TGA-CdTe-QDs to CPZ molecules, whereas the fluorescence peak of B-CDs is unaffected. Therefore, a new fluorimetric platform was prepared for the assay of CPZ in the range of 2.2 × 10-10 to 5.0 × 10-9 M with a detection limit of 1.3 × 10-10 M. Moreover, the practicability of the designed strategy was investigated for the detection of CPZ in biological samples and the results demonstrate that it possesses considerable potential to be utilized in practical applications.

Rapid colorimetric sensing of chlorpromazine HCl antipsychotic through in situ growth of gold nanoparticles

Antipsychotic drugs like chlorpromazine hydrochloride (CPZ) are widely used to treat mental illnesses but can accumulate in the environment if not properly disposed of. Long-term exposure to trace levels of such pharmaceuticals may pose health risks. This study reports a colorimetric assay for detection of the antipsychotic drug chlorpromazine hydrochloride (CPZ) based on its ability to reduce gold ions and form gold nanoparticles (AuNPs). Optimization of reaction conditions such as pH, temperature and reagent concentrations enabled quantitative analysis of CPZ concentrations from 0.1-30 μg mL-1, with a detection limit of 0.06 μg mL-1, 0.23 μg mL-1 quantification limit and less than 3.5% RSD. The AuNPs exhibited a characteristic surface plasmon resonance band at 527 nm detectable by UV-vis spectrophotometry. Method validation with spiked serum, urine and environmental water samples demonstrated acceptable accuracy and precision. Interfering substances showed minimal impact, indicating resilience and specificity. This rapid, inexpensive colorimetric assay could facilitate environmental monitoring and biomedical analysis of antipsychotic drugs.

An electrochemical chlorpromazine sensor based on a gold-copper bimetallic synergetic molecularly imprinted interface on an acupuncture needle electrode

Chlorpromazine (CPZ) is a medicine for nervous system disorders. Measuring CPZ in vivo can assist doctors in evaluating patients' blood drug concentration and monitoring drug metabolism. Therefore, an accurate in vivo detection of CPZ is crucial. In recent years, the acupuncture needle, traditionally used in Chinese medicine, has emerged as a potential electrode in the field of electrochemistry, with promising applications for in vivo detection. In this study, Au/Cu nanoparticles were electrodeposited onto an acupuncture needle electrode (ANE) to improve electrical conductivity and provide an electro-catalytic surface. Subsequently, 3-aminophenylboronic acid and CPZ were attracted to each other through intermolecular forces; at the same time, the interaction force of Au-S between CPZ and the AuNPs made the polymer layer grow around the CPZ molecules on the modified electrode surface. The imprinted nanocavities showed highly selective and sensitive detection performance for CPZ after elution. Inside the recognizable site and microenvironment of the cavities, the captured CPZ molecule provided a suitable configuration for the fluent electron transfer of the electroactive group within a short range from the Au/Cu bimetal. Under ideal conditions, the MIP/Au/Cu/ANE exhibited two good linear ranges of 0.1-100 μM and 100-1000 μM with a detection limit of 0.07 μM. Moreover, the sensors showed great selectivity, good stability and excellent repeatability, making them suitable for CPZ detection in human serum. This provides a novel idea for real-time and in vivo CPZ detection.

Application of electrochemical sensors based on nanomaterials modifiers in the determination of antipsychotics

At present, the content of antipsychotics in samples is always analyzed by traditional detection methods, including mass spectrometry (MS), spectrophotometry, fluorescence, capillary electrophoresis (CE). However, conventional methods are cumbersome and complex, require a large sample volume, many pre-processing steps, long analysis cycles, expensive instruments, and need well-trained detection capabilities personnel. In addition, patients with schizophrenia require frequent and painful blood collection procedures, which adds additional treatment costs and time burdens. In view of these factors, electrochemical methods have become the most promising candidate technology for timely analysis due to their low cost, simple operation, excellent sensitivity and specificity. As we all know, nanomaterials play an extremely important role in electrochemical sensing applications. As the sensor modifiers, nanomaterials enable electrochemical analysis to overcome the time-consuming and labor-intensive shortcomings of traditional detection methods, and greatly reduce the research cost. Nanomaterials modified electrodes can be used as sensors to determine the concentration of antipsychotics in organisms quickly and accurately, which is a bright spot in the application of nanomaterials. The combination of different nanomaterials can even form a nanocomposite with a synergistic effect. This paper firstly reviews the application of nanomaterials-modified sensors on the basis of research in the past ten years, reviews the use of nanomaterial-modified sensors to quickly and accurately determine the concentration of antipsychotics in biological samples, and demonstrates a new idea of using nanomaterials sensors for drug monitoring and determination. At the end of this review, a brief overview is given of the limitations and the future prospects of nanomaterial sensors for the determination of antipsychotics concentrations.

A Versatile and Ultrasensitive Electrochemical Sensing Platform for Detection of Chlorpromazine Based on Nitrogen-Doped Carbon Dots/Cuprous Oxide Composite

The excessive intake of chlorpromazine (CPZ) adversely affects human health profoundly, leading to a series of severe diseases such as hepatomegaly and dyskinesia. The rapid and precise detection of CPZ in real samples is of great significance for its effective surveillance. Herein, a versatile and sensitive electrochemical sensor was developed for the detection of antipsychotic drug CPZ based on a Nafion (Nf)-supported nitrogen-doped carbon dots/cuprous oxide (N-CDs/Cu₂O) composite. The as-synthesized N-CDs/Cu₂O composite was systematically characterized using various physicochemical techniques. The developed composite-based sensor displayed excellent performance towards CPZ determination in a dynamic linear range of 0.001-230 µM with the detection limit of 25 nM. Remarkably, the developed sensor displayed good performance in terms of sensitivity and selectivity. Furthermore, good anti-interference properties toward CPZ determination were attained despite the presence of highly concentrated interfering compounds. Therefore, this composite could be a notable potential modifier to enhance electrocatalytic activity onto the surface of the electrode. Finally, N-CDs/Cu₂O/Nf-based sensor was effectively applied for quantification of CPZ in human urine and pharmaceutical formulation samples.